Please login to the form below
Economic value added (EVA)
EVA (Economic Value Added) is an estimate of true economic profit after making corrective adjustments to Generally Accepted Accounting Principles (GAAP) accounting, including deducting the opportunity cost of equity capital.
The equation for measuring EVA is as follows:
EVA = Net Operating Profit After Taxes (NOPAT) - (Capital * Cost of Capital)
See also:
Cost–benefit analysis
Cost-effective (healthcare economics)
Cost-effectiveness league table (healthcare economics)
Cost-effectiveness threshold (health economics)
Cost-minimisation analysis (CMA)
Cost consequences analysis (CCA)
COVID-19 Updates and Daily News
Featured jobs
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
-
Consultant Dermatologist (Freelance)
-
£110-180ph
- Senior Medical Writer, MRNA/ Covid 19, Medical Communications, U...
-
Highly competitive salary
- SAD/ Group Account Director, Medical Communications, Remote UK
-
Highly competitive salary
- UK trial of fourth vaccine dose shows increased protection against COVID-19
- Biogen and MedRhythms sign deal worth over $120m for digital therapeutics for MS patients
- EIT Health and Biogen announce winners of first ‘neurotechprize’
- Biogen and Eisai announce FDA submission for early Alzheimer’s treatment
- Roche reinforces commitment to the World Federation of Hemophilia Humanitarian Aid Program
- FDA limits use of Janssen’s COVID-19 vaccine
- Phase 3 trial of AstraZeneca and Avillion’s PT027 shows promise for asthma patients
- MHRA approves Infex Therapeutics’s study for treatment for non-cystic fibrosis patients
- Shionogi and F2G partner to develop antifungal treatment olorofim
- Viseven and Next Pharma Partnership Announcement
- Holistic Excellence
- Bristol Myers Squibb releases positive trial results for plaque psoriasis treatment
- Biogen retracts EMA application for Alzheimer's drug Aduhelm
- BioXcel Therapeutics begins phase 3 trial for acute agitation in Alzheimer’s patients
- Bristol Myers Squibb releases positive trial results for plaque psoriasis treatment
- Roche shares new positive Ocrevus data for MS patients
- WHO releases estimates of 14.9 million excess deaths during COVID-19 pandemic
- Patient journey mapping: exploring the clinical and the emotional journey
PMHub
Havas Life Medicom
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by...
